MOREPEN LABORATORIES LIMITED

USA Business

Morepen Bio Inc.
USA Business

Morepen Bio Inc. represents Morepen's US pharmaceutical business, focused on prescription products, over-the-counter medicines and pharmaceutical commercialization. Backed by Morepen's capabilities in API manufacturing, formulation development, regulatory submissions and pharmaceutical manufacturing, we aim to serve the evolving needs of the US healthcare market.

Prescription & pipeline

US Prescription & ANDA Products

Prescription / RxUS prescription product

Desloratadine Tablets USP

Strength
5 mg
Dosage form
Tablets
Market
United States

Pack sizes will be listed once confirmed.

ANDA / Prescription pipelineANDA Under Review — Approval Pending

Sitagliptin Tablets

Strengths
25 mg, 50 mg, 100 mg
Dosage form
Tablets
Market
United States

ANDA submitted to USFDA; approval pending. This product is not FDA-approved and is not offered for sale in the United States.

An ANDA submission is not approval. Products under ANDA review are shown for business-development information only and are not offered for sale in the United States.

Over-the-counter

US Over-the-Counter (OTC) Products

OTCUS OTC product

Senna Tablets

Strength
8.6 mg
Dosage form
Tablets
Market
United States

Pack sizes

  • 60-count bottle
  • 100-count bottle
  • 250-count bottle
  • 1000-count bottle

Package NDCs will be listed once verified. Contact our sales team to confirm current pack-size availability.

OTCUS OTC product

Docusate Sodium + Sennosides Tablets

Strength
Docusate Sodium 50 mg + Sennosides 8.6 mg
Dosage form
Tablets
Market
United States

Pack sizes

  • 30-count bottle
  • 60-count bottle
  • 100-count bottle
  • 1000-count bottle

Package NDCs will be listed once verified. Contact our sales team to confirm current pack-size availability.

Morepen Bio Inc. capabilities

Integrated Pharmaceutical Capabilities for the US Market

01

API Manufacturing

Active pharmaceutical ingredient manufacturing, connecting the US portfolio to Morepen's API base.

Explore API
02

Formulation Development

Development of finished-dose pharmaceutical formulations for target markets.

Explore Drug Product
03

ANDA & Regulatory Support

Preparing and supporting abbreviated new drug applications and the associated regulatory processes.

Explore ANDA development
04

Pharmaceutical Manufacturing

Manufacturing capabilities supporting pharmaceutical products across the development-to-supply path.

Explore Manufacturing
05

US Commercialization

Support for bringing eligible products to the US market through appropriate commercial channels.

Morepen Bio Inc. sales

Business Enquiry /
Contact Sales

For US pharmaceutical partners, distributors, wholesalers and other business customers interested in Morepen Bio Inc.'s prescription and OTC products.

Prefer email? Write to sales@morepeninc.com

Product safety and adverse events
Do not use this form for safety reporting or medical questions.

Official adverse event reporting

Tell us what you need.

Fields marked * are required. Keep the first note non-confidential.